Subscribe

Anika Therapeutics, Inc. (ANIK)

USD15.76 +0.24 (+1.55%)
US NASDAQ Healthcare Medical - Devices
Address 32 Wiggins Avenue 1730
Bedford, MA, US
CEO Stephen D. Griffin
IPO 1993-05-03
CIK 898437 ISIN US0352551081

Explore sections of this company profile

Description

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthritis. The company's joint preservation and restoration offerings are extensive, comprising approximately 150 bone-sparing joint technology products, alongside solutions for sports medicine soft tissue repair and orthopedic regenerative therapies. Furthermore, Anika leverages its HA expertise in a non-orthopedic product family, developing applications such as adhesion barriers, advanced wound care products, ophthalmic solutions, and ear, nose, and throat treatments. Anika Therapeutics, Inc. was established in 1983 and is based in Bedford, Massachusetts.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD15.76 +0.24 (+1.55%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
96.9K
Beta
0.23
Float Shares
12.67M
Free Float %
94.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.96% -2.78% -1.41% +43.78% +45.35% +52.76% +18.29% -42.88% -65.60% -66.42% +319.43%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (6 ratings, all time) Buy
Price Targets & DCF
Current price
15.76
DCF (Unlevered) 4.90 -68.9%
DCF (Levered) 24.19 +53.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
3.90
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Devices: +11.2%
    -5.9% Q1'26: +13.2% (vs Q1'25)
  • EPS growth Medical - Devices: +28.5%
    +80.2% Q1'26: -8.8% (vs Q1'25)
  • FCF margin FCF growth · Medical - Devices: +30.9%
    -11.1% Q1'26: -21.2% (vs Q1'25)
  • EBIT margin Medical - Devices: +6.2%
    -9.8% Q1'26: -18.5% (vs Q1'25)
  • ROIC Medical - Devices: +3.3%
    -10.0% Q1'26: -18.5% (vs Q1'25)
  • Share dilution Medical - Devices: 0.0%
    -2.6% Q1'26: -5.4% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    -4.55× Q1'26: -1.58× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.16) × ERP
WACC = 90% × Ke + 10% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 4.85 Current price: 15.76
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 1998
actual
Dec 2004
actual
Dec 2006
actual
Dec 2012
actual
Dec 2013
actual
Dec 2014
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
2 Rev. Ana.
1 EPS Ana.
Dec 2027
2 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
13.90M
est: 20.32M (-31.6%)
26.47M
est: 18.04M (+46.7%)
26.84M
est: 25.68M (+4.5%)
71.36M
est: 71.42M (-0.1%)
75.08M
est: 67.32M (+11.5%)
105.59M
est: 73.81M (+43.1%)
93.00M
est: 90.30M (+3.0%)
103.38M
est: 102.49M (+0.9%)
113.42M
est: 113.88M (-0.4%)
105.56M
est: 104.77M (+0.8%)
114.61M
est: 112.41M (+2.0%)
130.46M
est: 131.28M (-0.6%)
147.79M
est: 144.03M (+2.6%)
113.83M
est: 154.31M (-26.2%)
120.79M
est: 166.88M (-27.6%)
119.91M
est: 150.20M (-20.2%)
112.82M
est: 111.03M (+1.6%)
118.61M
118.49M – 118.72M
+6.8% YoY
126.58M
125.56M – 127.60M
+6.7% YoY
133.61M
132.99M – 134.23M
+5.6% YoY
EBITDA
3.37M
est: 7.99M (-57.8%)
14.53M
est: 5.02M (+189.1%)
5.81M
est: 7.17M (-19.0%)
26.78M
est: 21.01M (+27.5%)
32.03M
est: 32.77M (-2.2%)
61.45M
est: 4.04M (+1,421.8%)
51.91M
est: 34.31M (+51.3%)
54.34M
est: 39.67M (+37.0%)
50.02M
est: 42.93M (+16.5%)
27.66M
est: -7.45M (+471.5%)
40.24M
est: 37.28M (+7.9%)
-1.00M
est: 7.18M (-114.0%)
-4.16M
est: 7.88M (-152.8%)
18.16M
est: 18.39M (-1.3%)
15.06M
est: 7.81M (+92.8%)
3.02M
est: 7.03M (-57.0%)
-5.32M
est: 5.20M (-202.4%)
5.55M
5.55M – 5.56M
+6.8% YoY
5.93M
5.88M – 5.97M
+6.7% YoY
6.25M
6.23M – 6.28M
+5.6% YoY
EBIT
2.57M
est: 5.42M (-52.5%)
13.82M
est: 4.28M (+222.8%)
5.43M
est: 4.83M (+12.4%)
22.25M
est: 16.85M (+32.1%)
32.61M
est: 28.77M (+13.3%)
61.51M
est: -3.53M (+1,841.5%)
48.13M
est: 31.66M (+52.0%)
50.61M
est: 36.81M (+37.5%)
45.73M
est: 38.50M (+18.8%)
21.75M
est: -17.56M (+223.9%)
34.25M
est: 30.47M (+12.4%)
-14.47M
est: -6.28M (-130.3%)
-18.48M
est: -6.89M (-168.1%)
3.67M
est: 567.0K (+547.3%)
844.0K
est: -7.55M (+111.2%)
-5.10M
est: -6.80M (+25.0%)
-11.05M
est: -5.03M (-119.9%)
-5.37M
-5.37M – -5.36M
-6.8% YoY
-5.73M
-5.78M – -5.68M
-6.7% YoY
-6.05M
-6.08M – -6.02M
-5.6% YoY
Net Income
4.30M
est: 6.72M (-36.0%)
11.19M
est: 9.24M (+21.1%)
4.60M
est: 4.22M (+9.0%)
11.76M
est: 10.04M (+17.1%)
20.57M
est: 18.15M (+13.3%)
38.32M
est: 46.43M (-17.5%)
30.76M
est: 20.27M (+51.8%)
32.55M
est: 23.65M (+37.6%)
31.82M
est: 27.43M (+16.0%)
18.72M
est: -14.73M (+227.1%)
27.19M
est: 24.23M (+12.2%)
-23.98M
est: -10.08M (-137.8%)
4.13M
est: 5.84M (-29.2%)
-14.86M
est: -241.3K (-6,058.3%)
-82.67M
est: -72.33M (-14.3%)
-56.39M
est: 1.43M (-4,032.3%)
-10.88M
est: -8.82M (-23.4%)
-1.72M
-1.73M – -1.71M
+80.5% YoY
2.22M
2.21M – 2.24M
+229.2% YoY
9.46M
9.41M – 9.52M
+325.8% YoY
SGA
2.70M
est: 4.44M (-39.2%)
6.04M
est: 4.14M (+46.1%)
6.68M
est: 6.15M (+8.5%)
14.73M
est: 13.68M (+7.7%)
12.94M
est: 11.13M (+16.2%)
15.07M
est: 16.20M (-6.9%)
14.83M
est: 10.30M (+43.9%)
18.01M
est: 13.29M (+35.5%)
21.54M
est: 20.08M (+7.3%)
34.34M
est: 80.90M (-57.6%)
34.95M
est: 33.14M (+5.5%)
60.06M
est: 62.26M (-3.5%)
74.10M
est: 68.30M (+8.5%)
51.23M
est: 93.42M (-45.2%)
59.93M
est: 78.30M (-23.5%)
55.56M
est: 70.47M (-21.2%)
49.09M
est: 52.09M (-5.8%)
55.65M
55.59M – 55.70M
+6.8% YoY
59.39M
58.91M – 59.87M
+6.7% YoY
62.69M
62.40M – 62.98M
+5.6% YoY
EPS
0.38
est: 0.34 (+13.4%)
0.98
est: 0.15 (+575.9%)
0.43
est: 0.37 (+16.2%)
0.89
est: 0.71 (+25.4%)
1.46
est: 0.88 (+65.9%)
2.61
est: 1.68 (+55.8%)
2.06
est: 1.83 (+12.7%)
2.22
est: 2.14 (+3.7%)
2.18
est: 1.91 (+14.4%)
1.30
est: 1.08 (+20.6%)
1.93
est: 2.04 (-5.4%)
-1.69
est: -0.69 (-146.7%)
0.29
est: 0.40 (-26.9%)
-1.02
est: -0.92 (-10.9%)
-5.64
est: -5.04 (-11.8%)
-3.83
est: 0.10 (-3,930.0%)
-0.76
est: -0.62 (-23.6%)
-0.12
-0.12 – -0.12
+80.5% YoY
0.16
0.15 – 0.16
+229.2% YoY
0.66
0.66 – 0.66
+325.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-08 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-07 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-06 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-05 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-04 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-01 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-30 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-29 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-28 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-27 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-24 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-23 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-22 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-21 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-20 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-17 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-16 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
13.53M
OE per share TTM
0.89
Owner's Yield
6.88%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
57.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
25
Total invested
11.76M
Insider transactions (90d)
1
Beneficial owners (>5%)
30
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 (1)Names of reporting persons. BlackRock, Inc. 2.53M 17.30% HC Delaware 2023-01-20
2 (1) BlackRock, Inc. 1.76M 11.90% 1.76M HC Delaware 2024-10-23
3 KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC95-4575414 1.55M 10.88% 1.11M 435.3K 1.11M 435.3K IA 2021-02-11
4 Bradley F. Simon 1.49M 4.00% 1.42M HC, IN Illinois 2022-10-07
5 Douglas Granat 1.49M 4.00% 1.42M HC, IN Illinois 2022-10-07
6 Lawrence A. Oberman 1.49M 4.00% 1.42M HC, IN Illinois 2022-10-07
7 Steven G. Simon 1.49M 4.00% 1.42M HC, IN Illinois 2022-10-07
8 Steven R. Monieson 1.49M 4.00% 1.42M HC, IN Illinois 2022-10-07
9 Trigran Investments, Inc. 1.49M 4.00% 1.42M IA, CO Illinois 2022-10-07
10 Wellington Management Company LLP 1.13M 7.73% 918.0K IA Delaware 2018-02-08
11 Financial, Inc. 1.00M 7.07% 1.00M 1.00M HC 2021-02-12
12 Management Investment Advisers, LLC 1.00M 7.06% 1.00M 1.00M IA 2021-02-12
13 The Vanguard Group - 23-1945930 934.3K 6.57% 14.4K 910.1K 24.2K IA Pennsylvania 2021-02-10
14 Asset Management, LLC 932.7K 6.57% 932.7K 932.7K IA 2021-02-12
15 Caligan Partners LP 902.1K 6.20% 902.1K 10.00 IA, PN Delaware 2023-08-17
16 David Johnson 902.1K 6.20% 902.1K 10.00 IN United States 2023-08-17
17 30-0447847 856.1K 5.90% 833.9K 856.1K IA Delaware Limited Partnership 2022-02-08
18 STATE STREET CORPORATION 798.6K 5.53% 767.7K 798.6K HC 2022-02-10
19 13-3127734 683.4K 4.73% 683.4K 683.4K HC Delaware 2022-02-10
20 26-0385758 683.4K 4.73% 683.4K 683.4K IA Delaware 2022-02-10
21 Wellington Group Holdings LLP 133.9K 0.94% 133.9K HC Delaware 2019-02-12
22 Wellington Investment Advisors Holdings LLP 133.9K 0.94% 133.9K HC Delaware 2019-02-12
23 Wellington Management Group LLP 133.9K 0.94% 133.9K HC Massachusetts 2019-02-12
24 Avidity Capital Partners (GP) LLC 0.00% OO 2022-02-14
25 Avidity Capital Partners Fund (GP) LP 0.00% PN, OO 2022-02-14
26 Avidity Partners Management (GP) LLC 0.00% OO 2022-02-14
27 Avidity Partners Management LP 0.00% IA, PN 2022-02-14
28 David Witzke 0.00% IN 2022-02-14
29 GAMCO Investors, Inc. 0.00% 26.3K 1.1K 818.5K 26.6K HC, CO Pennsylvania 2017-02-09
30 Michael Gregory 0.00% IN 2022-02-14

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
25
-100 vs prev Q
New positions
7
Closed positions
107
Increased
15
Reduced
7
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 BLACKROCK, INC. 1.65M -87.2K (-5.0%) 15.90M -472.5K (-2.9%) 11.52% -0.633 pp 0.00% +0.000 pp USD22.75 -57.8% 6 qtrs
2 CALIGAN PARTNERS LP 1.44M +— (+0.0%) 13.79M +301.4K (+2.2%) 9.99% -0.021 pp 1.14% -0.632 pp USD25.79 -62.7% 13 qtrs
3 VANGUARD GROUP INC 779.2K -1.5K (-0.2%) 7.49M +149.5K (+2.0%) 5.43% -0.022 pp 0.00% +0.000 pp USD30.09 -68.1% 84 qtrs
4 MORGAN STANLEY 772.2K +377.5K (+95.6%) 7.42M +3.7M (+100.0%) 5.38% +2.623 pp 0.00% +0.000 pp USD12.07 -20.4% 51 qtrs
5 ACADIAN ASSET MANAGEMENT LLC 606.5K -26.2K (-4.1%) 5.82M -120.0K (-2.0%) 4.22% -0.192 pp 0.01% -0.001 pp USD19.84 -51.6% 23 qtrs
6 BOOTHBAY FUND MANAGEMENT, LLC 534.5K -5.1K (-1.0%) 5.14M +64.0K (+1.3%) 3.72% -0.044 pp 0.08% +0.003 pp USD24.80 -61.3% 14 qtrs
7 RENAISSANCE TECHNOLOGIES LLC 515.7K -17.3K (-3.2%) 4.96M -54.3K (-1.1%) 3.59% -0.128 pp 0.01% +0.001 pp USD35.82 -73.2% 76 qtrs
8 CAPITAL MANAGEMENT CORP /VA 500.5K -50.8K (-9.2%) 4.81M -372.3K (-7.2%) 3.48% -0.362 pp 0.79% -0.026 pp USD16.59 -42.1% 10 qtrs
9 DIMENSIONAL FUND ADVISORS LP 494.3K -106.8K (-17.8%) 4.75M -900.4K (-15.9%) 3.44% -0.753 pp 0.00% 0.000 pp USD27.48 -65.0% 51 qtrs
10 STATE STREET CORP 336.5K +13.2K (+4.1%) 3.23M +194.4K (+6.4%) 2.34% +0.087 pp 0.00% +0.000 pp USD32.56 -70.5% 51 qtrs
11 GEODE CAPITAL MANAGEMENT, LLC 325.5K -10.2K (-3.0%) 3.13M -27.2K (-0.9%) 2.27% -0.076 pp 0.00% +0.000 pp USD32.73 -70.6% 78 qtrs
12 D. E. SHAW & CO., INC. 298.0K +122.7K (+70.0%) 2.86M +1.2M (+73.8%) 2.07% +0.852 pp 0.00% +0.001 pp USD18.22 -47.3% 40 qtrs
13 TWO SIGMA INVESTMENTS, LP 233.8K +153.9K (+192.5%) 2.25M +1.5M (+199.1%) 1.63% +1.070 pp 0.00% +0.002 pp USD9.54 +0.7% 2 qtrs
14 JACOBS LEVY EQUITY MANAGEMENT, INC 195.6K +85.8K (+78.1%) 1.88M +847.3K (+82.1%) 1.36% +0.596 pp 0.01% +0.003 pp USD13.35 -28.0% 5 qtrs
15 TRIGRAN INVESTMENTS, INC. 168.4K -1.5M (-89.6%) 1.62M -13.6M (-89.4%) 1.17% -10.140 pp 0.32% -2.444 pp USD27.77 -65.4% 19 qtrs
16 GOLDMAN SACHS GROUP INC 164.9K +100.0K (+153.8%) 1.58M +974.2K (+159.5%) 1.15% +0.695 pp 0.00% +0.000 pp USD11.85 -18.9% 50 qtrs
17 JANE STREET GROUP, LLC 134.8K +85.0K (+171.0%) 1.30M +827.6K (+177.0%) 0.94% +0.591 pp 0.00% +0.000 pp USD11.46 -16.1% 13 qtrs
18 TWO SIGMA ADVISERS, LP 126.5K +89.6K (+242.9%) 1.22M +868.8K (+250.6%) 0.88% +0.623 pp 0.00% +0.002 pp USD12.43 -22.7% 42 qtrs
19 GSA CAPITAL PARTNERS LLP 122.1K +80.3K (+192.4%) 1.17M +781.0K (+199.2%) 0.85% +0.559 pp 0.10% +0.068 pp USD9.54 +0.7% 2 qtrs
20 ENVESTNET ASSET MANAGEMENT INC 117.9K -12.9K (-9.9%) 1.13M -96.6K (-7.9%) 0.82% -0.092 pp 0.00% +0.000 pp USD15.71 -38.8% 10 qtrs
21 NORTHERN TRUST CORP 111.7K -7.4K (-6.2%) 1.07M -46.1K (-4.1%) 0.78% -0.053 pp 0.00% +0.000 pp USD28.19 -65.9% 51 qtrs
22 TREXQUANT INVESTMENT LP 107.3K +62.6K (+140.1%) 1.03M +611.1K (+145.5%) 0.75% +0.435 pp 0.01% +0.005 pp USD9.52 +0.9% 2 qtrs
23 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 106.3K +2.4K (+2.3%) 1.02M +45.1K (+4.6%) 0.74% +0.015 pp 0.00% +0.000 pp USD35.38 -72.8% 55 qtrs
24 QUANTINNO CAPITAL MANAGEMENT LP 101.5K +43.0K (+73.3%) 975.9K +425.1K (+77.2%) 0.71% +0.298 pp 0.00% +0.001 pp USD9.64 -0.3% 3 qtrs
25 AMERICAN CENTURY COMPANIES INC 100.3K +42.2K (+72.5%) 964.1K +417.5K (+76.4%) 0.70% +0.293 pp 0.00% +0.000 pp USD14.11 -31.9% 11 qtrs
26 GLOBEFLEX CAPITAL L P 87.6K +— (+0.0%) 841.8K +18.4K (+2.2%) 0.61% -0.001 pp 0.13% +0.002 pp USD24.80 -61.3% 9 qtrs
27 MARSHALL WACE, LLP 87.2K +13.5K (+18.3%) 837.9K +144.9K (+20.9%) 0.61% +0.093 pp 0.00% +0.000 pp USD9.74 -1.3% 9 qtrs
28 DEUTSCHE BANK AG\ 81.3K +— (+0.0%) 781.2K +17.1K (+2.2%) 0.57% -0.001 pp 0.00% +0.000 pp USD22.68 -57.6% 50 qtrs
29 BNP PARIBAS ARBITRAGE, SNC 72.2K +56.9K (+372.9%) 693.7K +550.2K (+383.5%) 0.50% +0.396 pp 0.00% +0.000 pp USD9.72 -1.1% 49 qtrs
30 BARCLAYS PLC 70.5K +37.8K (+115.9%) 677.6K -129.2K (-16.0%) 0.49% +0.263 pp 0.00% +0.000 pp USD15.08 -36.3% 51 qtrs
31 AQR CAPITAL MANAGEMENT LLC 69.3K +19.8K (+40.1%) 665.8K +200.8K (+43.2%) 0.48% +0.137 pp 0.00% +0.000 pp USD11.06 -13.1% 15 qtrs
32 IRONWOOD INVESTMENT MANAGEMENT LLC 65.6K +37.4K (+132.7%) 630.5K +365.5K (+137.9%) 0.46% +0.260 pp 0.27% +0.150 pp USD15.46 -37.8% 9 qtrs
33 MAN GROUP PLC 64.3K +49.5K (+335.0%) 617.7K +478.8K (+344.7%) 0.45% +0.345 pp 0.00% +0.001 pp USD9.81 -2.0% 3 qtrs
34 CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 59.9K +13.9K (+30.4%) 575.5K +143.6K (+33.3%) 0.42% +0.096 pp 0.00% +0.000 pp USD19.14 -49.8% 12 qtrs
35 DIKER MANAGEMENT LLC 58.2K +1.4K (+2.4%) 559.4K +25.1K (+4.7%) 0.41% +0.009 pp 0.43% +0.001 pp USD23.43 -59.0% 52 qtrs
36 POINT72 ASSET MANAGEMENT, L.P. 58.1K +58.1K (+100.0%) 558.4K +558.4K (+100.0%) 0.40% +0.405 pp 0.00% +0.001 pp USD9.61 +0.0% 1 qtrs NEW
37 AMERIPRISE FINANCIAL INC 53.2K +20.3K (+61.4%) 511.6K +201.5K (+65.0%) 0.37% +0.141 pp 0.00% +0.000 pp USD19.08 -49.6% 55 qtrs
38 NUVEEN, LLC 53.2K +22.8K (+75.2%) 511.3K +225.8K (+79.1%) 0.37% +0.159 pp 0.00% +0.000 pp USD12.70 -24.3% 4 qtrs
39 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 53.0K +— (+0.0%) 509.3K +11.1K (+2.2%) 0.37% -0.001 pp 0.00% +0.000 pp USD20.14 -52.3% 10 qtrs
40 50.4K +50.4K (+100.0%) 484.4K +484.4K (+100.0%) 0.35% +0.351 pp 0.05% +0.053 pp USD9.61 +0.0% 1 qtrs NEW
41 STATE OF WISCONSIN INVESTMENT BOARD 49.6K +2.6K (+5.5%) 476.6K +34.7K (+7.8%) 0.35% +0.017 pp 0.00% +0.000 pp USD15.46 -37.8% 9 qtrs
42 BANK OF AMERICA CORP /DE/ 48.3K +18.6K (+62.7%) 464.2K +185.2K (+66.4%) 0.34% +0.129 pp 0.00% +0.000 pp USD20.07 -52.1% 52 qtrs
43 ADVYZON INVESTMENT MANAGEMENT, LLC 48.3K +28.2K (+139.8%) 464.1K +274.8K (+145.2%) 0.34% +0.196 pp 0.05% +0.021 pp USD9.52 +0.9% 2 qtrs
44 HSBC HOLDINGS PLC 48.3K +48.3K (+100.0%) 464.1K +464.1K (+100.0%) 0.34% +0.337 pp 0.00% +0.000 pp USD9.61 +0.0% 1 qtrs NEW
45 CITADEL ADVISORS LLC 47.1K +27.7K (+142.8%) 452.3K +270.1K (+148.2%) 0.33% +0.193 pp 0.00% +0.000 pp USD14.17 -32.2% 14 qtrs
46 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 46.4K -1.5K (-3.2%) 445.7K -4.7K (-1.0%) 0.32% -0.011 pp 0.00% +0.000 pp USD24.46 -60.7% 8 qtrs
47 QUADRATURE CAPITAL LTD 44.7K +44.7K (+100.0%) 429.9K +429.9K (+100.0%) 0.31% +0.312 pp 0.00% +0.004 pp USD9.61 +0.0% 1 qtrs NEW
48 R SQUARED LTD 41.6K +24.4K (+141.7%) 399.6K +237.9K (+147.1%) 0.29% +0.170 pp 0.19% +0.117 pp USD9.91 -3.0% 5 qtrs
49 BANK OF NEW YORK MELLON CORP 40.5K -9.6K (-19.1%) 389.3K -81.6K (-17.3%) 0.28% -0.068 pp 0.00% +0.000 pp USD32.81 -70.7% 66 qtrs
50 ENGINEERS GATE MANAGER LP 40.3K +16.2K (+66.9%) 387.1K +160.3K (+70.7%) 0.28% +0.112 pp 0.00% +0.002 pp USD12.86 -25.3% 10 qtrs
51 JPMORGAN CHASE & CO 33.3K +6.5K (+24.1%) 320.3K +67.8K (+26.9%) 0.23% +0.045 pp 0.00% +0.000 pp USD16.81 -42.8% 41 qtrs
52 FMR LLC 33.2K +12.5K (+60.1%) 319.1K +124.1K (+63.6%) 0.23% +0.087 pp 0.00% +0.000 pp USD17.93 -46.4% 30 qtrs
53 CI PRIVATE WEALTH, LLC 32.2K +1.3K (+4.3%) 309.7K +19.2K (+6.6%) 0.22% +0.009 pp 0.00% +0.000 pp USD9.41 +2.1% 2 qtrs
54 CERITY PARTNERS LLC 31.8K +1.6K (+5.2%) 305.4K +21.5K (+7.6%) 0.22% +0.011 pp 0.00% +0.000 pp USD14.64 -34.4% 4 qtrs
55 OBJECTIVITY SQUARED, LLC 31.6K +31.6K (+100.0%) 303.4K +303.4K (+100.0%) 0.22% +0.220 pp 0.17% +0.170 pp USD9.61 +0.0% 1 qtrs NEW
56 UBS GROUP AG 28.5K -238.0 (-0.8%) 274.3K +3.8K (+1.4%) 0.20% -0.002 pp 0.00% +0.000 pp USD11.67 -17.7% 45 qtrs
57 MILLENNIUM MANAGEMENT LLC 26.2K -60.7K (-69.9%) 251.3K -565.3K (-69.2%) 0.18% -0.424 pp 0.00% 0.000 pp USD14.36 -33.1% 21 qtrs
58 DIAMETRIC CAPITAL, LP 25.6K +25.6K (+100.0%) 246.0K +246.0K (+100.0%) 0.18% +0.178 pp 0.07% +0.066 pp USD9.61 +0.0% 1 qtrs NEW
59 OCCUDO QUANTITATIVE STRATEGIES LP 25.5K +15.4K (+152.5%) 245.2K +150.2K (+158.1%) 0.18% +0.107 pp 0.02% +0.005 pp USD9.53 +0.8% 2 qtrs
60 INVESCO LTD. 25.3K +1.8K (+7.9%) 242.9K +22.6K (+10.3%) 0.18% +0.013 pp 0.00% +0.000 pp USD32.93 -70.8% 49 qtrs
61 SUSQUEHANNA INTERNATIONAL GROUP, LLP 24.2K +24.2K (+100.0%) 232.7K +232.7K (+100.0%) 0.17% +0.169 pp 0.00% +0.000 pp USD9.61 +0.0% 4 qtrs
62 XTX TOPCO LTD 22.3K +9.5K (+74.3%) 213.8K +93.8K (+78.1%) 0.15% +0.066 pp 0.01% -0.001 pp USD9.49 +1.3% 2 qtrs
63 CANADA PENSION PLAN INVESTMENT BOARD 22.0K +22.0K (+100.0%) 211.4K +211.4K (+100.0%) 0.15% +0.153 pp 0.00% +0.000 pp USD9.61 +0.0% 1 qtrs NEW
64 PHARVISION ADVISERS, LLC 21.5K -19.9K (-48.0%) 206.8K -182.2K (-46.8%) 0.15% -0.139 pp 0.10% -0.114 pp USD9.40 +2.2% 2 qtrs
65 ALLIANCEBERNSTEIN L.P. 20.5K +— (+0.0%) 196.5K +4.3K (+2.2%) 0.14% 0.000 pp 0.00% +0.000 pp USD39.92 -75.9% 54 qtrs
66 JUMP FINANCIAL, LLC 20.1K +20.1K (+100.0%) 193.4K +193.4K (+100.0%) 0.14% +0.140 pp 0.00% +0.002 pp USD9.61 +0.0% 1 qtrs NEW
67 NOESIS CAPITAL MANGEMENT CORP 19.4K +— (+0.0%) 186.4K +4.1K (+2.2%) 0.14% 0.000 pp 0.03% -0.001 pp USD15.03 -36.1% 4 qtrs
68 RHUMBLINE ADVISERS 18.1K -2.2K (-10.7%) 174.4K -16.6K (-8.7%) 0.13% -0.015 pp 0.00% +0.000 pp USD35.59 -73.0% 51 qtrs
69 BRIDGEWAY CAPITAL MANAGEMENT, LLC 17.5K +— (+0.0%) 168.2K +3.7K (+2.2%) 0.12% 0.000 pp 0.00% +0.000 pp USD10.58 -9.2% 3 qtrs
70 OXFORD ASSET MANAGEMENT LLP 16.6K +16.6K (+100.0%) 159.7K +159.7K (+100.0%) 0.12% +0.116 pp 0.07% +0.065 pp USD9.61 +0.0% 1 qtrs NEW
71 QUBE RESEARCH & TECHNOLOGIES LTD 16.5K -905.0 (-5.2%) 158.8K -5.0K (-3.1%) 0.12% -0.007 pp 0.00% +0.000 pp USD19.96 -51.9% 10 qtrs
72 CETERA INVESTMENT ADVISERS 16.5K -4.6K (-21.9%) 158.1K -39.8K (-20.1%) 0.11% -0.032 pp 0.00% 0.000 pp USD12.63 -23.9% 4 qtrs
73 CITIGROUP INC 16.2K +16.0K (+9,167.4%) 155.9K +154.2K (+9,374.5%) 0.11% +0.112 pp 0.00% +0.000 pp USD9.77 -1.6% 54 qtrs
74 STRS OHIO 15.6K +1.7K (+12.2%) 149.9K +19.3K (+14.7%) 0.11% +0.012 pp 0.00% +0.000 pp USD9.42 +2.0% 2 qtrs
75 PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 15.6K +7.3K (+88.4%) 149.8K +72.1K (+92.6%) 0.11% +0.051 pp 0.00% +0.000 pp USD13.25 -27.5% 5 qtrs
76 WELLS FARGO & COMPANY/MN 14.7K +4.5K (+43.7%) 141.0K +45.1K (+46.9%) 0.10% +0.031 pp 0.00% +0.000 pp USD17.72 -45.8% 57 qtrs
77 NEWEDGE ADVISORS, LLC 14.5K +14.5K (+100.0%) 139.3K +139.3K (+100.0%) 0.10% +0.101 pp 0.00% +0.001 pp USD9.61 +0.0% 1 qtrs NEW
78 LOS ANGELES CAPITAL MANAGEMENT LLC 14.2K -12.0K (-45.8%) 138.4K -107.2K (-43.7%) 0.10% -0.084 pp 0.00% 0.000 pp USD9.40 +2.2% 46 qtrs
79 JAIN GLOBAL LLC 14.2K +14.2K (+100.0%) 136.9K +136.9K (+100.0%) 0.10% +0.099 pp 0.00% +0.001 pp USD9.61 +0.0% 1 qtrs NEW
80 WILLIAMS & NOVAK, LLC 14.2K +3.4K (+30.9%) 136.4K +34.5K (+33.9%) 0.10% +0.023 pp 0.10% +0.024 pp USD9.45 +1.7% 2 qtrs
81 MERCER GLOBAL ADVISORS INC /ADV 12.7K +12.7K (+100.0%) 122.5K +122.5K (+100.0%) 0.09% +0.089 pp 0.00% +0.000 pp USD9.61 +0.0% 1 qtrs NEW
82 INSCRIPTION CAPITAL, LLC 12.7K +12.7K (+100.0%) 121.7K +121.7K (+100.0%) 0.09% +0.088 pp 0.01% +0.013 pp USD9.61 +0.0% 1 qtrs NEW
83 ASSENAGON ASSET MANAGEMENT S.A. 12.6K -33.2K (-72.4%) 121.4K -309.5K (-71.8%) 0.09% -0.232 pp 0.00% 0.000 pp USD9.40 +2.2% 2 qtrs
84 IEQ CAPITAL, LLC 10.1K +10.1K (+100.0%) 96.8K +96.8K (+100.0%) 0.07% +0.070 pp 0.00% +0.000 pp USD9.61 +0.0% 1 qtrs NEW
85 CWM, LLC 8.5K +1.1K (+14.5%) 82.0K +12.0K (+17.1%) 0.06% +0.007 pp 0.00% +0.000 pp USD10.20 -5.8% 14 qtrs
86 MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 6.0K +176.0 (+3.0%) 57.4K +2.9K (+5.3%) 0.04% +0.001 pp 0.00% +0.000 pp USD24.60 -60.9% 7 qtrs
87 VERSANT CAPITAL MANAGEMENT, INC 3.6K +1.1K (+44.1%) 34.1K +11.0K (+47.3%) 0.02% +0.008 pp 0.00% +0.001 pp USD11.23 -14.4% 15 qtrs
88 NEW YORK STATE COMMON RETIREMENT FUND 3.4K +— (+0.0%) 32.9K +719.0 (+2.2%) 0.02% +0.000 pp 0.00% +0.000 pp USD46.66 -79.4% 49 qtrs
89 POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 3.3K +— (+0.0%) 31.3K +685.0 (+2.2%) 0.02% +0.000 pp 0.00% +0.000 pp USD16.46 -41.6% 5 qtrs
90 PNC FINANCIAL SERVICES GROUP, INC. 1.8K -15.0 (-0.8%) 17.4K +241.0 (+1.4%) 0.01% 0.000 pp 0.00% +0.000 pp USD11.62 -17.3% 51 qtrs
91 RUSSELL INVESTMENTS GROUP, LTD. 1.7K -279.0 (-14.0%) 16.5K -2.3K (-12.0%) 0.01% -0.002 pp 0.00% +0.000 pp USD11.56 -16.9% 37 qtrs
92 QUEST PARTNERS LLC 1.6K +— (+0.0%) 15.4K +337.0 (+2.2%) 0.01% +0.000 pp 0.00% 0.000 pp USD9.40 +2.2% 9 qtrs
93 TOWER RESEARCH CAPITAL LLC (TRC) 1.6K -189.0 (-10.6%) 15.3K -1.4K (-8.6%) 0.01% -0.001 pp 0.00% 0.000 pp USD13.64 -29.5% 26 qtrs
94 QUARRY LP 1.6K -6.0K (-78.9%) 15.3K -55.7K (-78.5%) 0.01% -0.042 pp 0.00% -0.013 pp USD9.40 +2.2% 2 qtrs
95 NISA INVESTMENT ADVISORS, LLC 1.4K +1.4K (+3,407.3%) 13.8K +13.4K (+3,489.4%) 0.01% +0.010 pp 0.00% +0.000 pp USD9.64 -0.3% 48 qtrs
96 MAI CAPITAL MANAGEMENT 1.3K +11.0 (+0.9%) 12.5K +378.0 (+3.1%) 0.01% +0.000 pp 0.00% +0.000 pp USD14.98 -35.8% 4 qtrs
97 AMERITAS INVESTMENT PARTNERS, INC. 1.2K +— (+0.0%) 11.6K +252.0 (+2.2%) 0.01% +0.000 pp 0.00% +0.000 pp USD42.87 -77.6% 36 qtrs
98 LEGAL & GENERAL GROUP PLC 1.1K +— (+0.0%) 10.4K +227.0 (+2.2%) 0.01% +0.000 pp 0.00% +0.000 pp USD35.32 -72.8% 46 qtrs
99 HUNTINGTON NATIONAL BANK 944.00 +135.0 (+16.7%) 9.1K +1.5K (+19.3%) 0.01% +0.001 pp 0.00% +0.000 pp USD10.24 -6.2% 35 qtrs
100 ROYAL BANK OF CANADA 815.00 +261.0 (+47.1%) 8.0K +3.0K (+60.0%) 0.01% +0.002 pp 0.00% +0.000 pp USD25.84 -62.8% 51 qtrs
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 63 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Xtrackers S&P Global Infrastructure Swap UCITS ETF 1C XGID.L 0.64% 4.61M 0.60%
2 Invesco NASDAQ Future Gen 200 ETF QQQS 0.54% 117.8K 0.20%
3 Royce Quant Small-Cap Quality Value ETF SQLV 0.20% 56.9K 0.60%
4 iShares Micro-Cap ETF IWC 0.04% 600.2K 0.60%
5 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC 0.03% 293.0K 0.20%
6 Xtrackers CSI300 Swap UCITS ETF XCHA.L 0.02% 353.2K 0.50%
7 Avantis U.S. Small Cap Equity ETF AVSC 0.01% 375.0K 0.25%
8 Dimensional - US Small Cap Value ETF DFSV 0.01% 956.0K 0.30%
9 JPMorgan Diversified Return U.S. Small Cap Equity ETF JPSE 0.01% 71.3K 0.29%
10 iShares Russell 2000 Value ETF IWN 0.01% 1.62M 0.24%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
12.2K
Shares disposed
Cash buys
1.00
Cash sales
Net activity
+12,200
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-04-30 Griffin Stephen D. Director / Officer P-Purchase A Common Stock 12,200 12.29 149.9K 36,163 D
2026-03-19 McLeod Ian Officer A-Award A Premium Priced Stock Appreciation Rights 17,663 15.60 275.5K 17,663 D
2026-03-15 McLeod Ian Officer M-Exempt A Common Stock 2,658 0.00 24,888 D
2026-03-15 Colleran David Officer M-Exempt D Restricted Stock Unit 6,449 0.00 6,448 D
2026-03-15 Blanchard Cheryl R Director M-Exempt A Common Stock 25,131 0.00 270,892 D
2026-03-14 McLeod Ian Officer M-Exempt A Common Stock 3,774 0.00 22,518 D
2026-03-14 Griffin Stephen D. Director / Officer M-Exempt A Common Stock 12,824 0.00 23,495 D
2026-03-14 Colleran David Officer M-Exempt D Restricted Stock Unit 9,388 0.00 18,777 D
2026-03-14 Blanchard Cheryl R Director M-Exempt A Common Stock 24,519 0.00 235,969 D
2026-02-01 Griffin Stephen D. Director / Officer A-Award A Stock Appreciation Rights 310,207 9.23 2.86M 310,207 D
2025-06-20 VOGT SUSAN L N Director A-Award A Common Stock 14,164 0.00 50,213 D
2025-06-20 Richard Stephen Director A-Award A Common Stock 14,164 0.00 47,871 D
2025-06-20 Larsen Glenn R. Director A-Award A Common Stock 14,164 0.00 50,258 D
2025-06-20 Jellison William R Director A-Award A Common Stock 14,164 0.00 20,403 D
2025-06-20 HENNEMAN JOHN B III Director A-Award A Common Stock 14,164 0.00 49,871 D
2025-06-20 Fischetti Gary P Director A-Award A Common Stock 14,164 0.00 41,613 D
2025-06-20 Capper Joseph H Director A-Award A Common Stock 14,164 0.00 20,403 D
2025-06-20 CONLEY SHERYL L Director A-Award A Common Stock 14,164 0.00 42,568 D
2025-06-03 Griffin Stephen D. Officer M-Exempt A Restricted Stock Unit 12,840 0.00 25,680 D
2025-04-05 McLeod Ian Officer Stock Option (Right to Buy) 2,362 29.60 69.9K 0 D
2025-03-17 Nunes Anne Officer M-Exempt A Common Stock 3,637 0.00 21,722 D
2025-03-17 Colleran David Officer M-Exempt D Restricted Stock Unit 6,448 0.00 12,897 D
2025-03-17 Blanchard Cheryl R Director / Officer M-Exempt D Restricted Stock Unit 25,132 0.00 50,263 D
2025-03-14 Nunes Anne Officer A-Award A Restricted Stock Unit 4,650 0.00 4,650 D
2025-03-14 Griffin Stephen D. Officer A-Award A Restricted Stock Unit 18,672 0.00 18,672 D
2025-03-14 Colleran David Officer A-Award A Restricted Stock Unit 13,669 0.00 13,669 D
2025-03-14 Blanchard Cheryl R Director / Officer A-Award A Restricted Stock Unit 71,403 0.00 71,403 D
2025-03-11 Nunes Anne Officer F-InKind D Common Stock 752 16.79 12.6K 18,085 D
2025-03-11 Colleran David Officer F-InKind D Common Stock 2,250 16.79 37.8K 43,399 D
2025-03-11 Blanchard Cheryl R Director / Officer M-Exempt D Restricted Stock Unit 30,060 0.00 0 D
2025-03-10 Nunes Anne Officer M-Exempt D Restricted Stock Unit 3,296 0.00 3,295 D
2025-03-10 Colleran David Officer F-InKind D Common Stock 1,604 16.62 26.7K 37,986 D
2025-03-10 Blanchard Cheryl R Director / Officer M-Exempt D Restricted Stock Unit 20,002 0.00 20,001 D
2024-10-01 Nunes Anne Officer M-Exempt A Common Stock 2,491 0.00 14,211 D
2024-07-09 VOGT SUSAN L N Director A-Award A Common Stock 5,771 0.00 36,049
2024-07-09 Richard Stephen Director A-Award A Common Stock 5,771 0.00 33,707
2024-07-09 Larsen Glenn R. Director A-Award A Common Stock 5,771 0.00 36,094
2024-07-09 Jellison William R Director A-Award A Common Stock 5,771 0.00 6,239
2024-07-09 HENNEMAN JOHN B III Director A-Award A Common Stock 5,771 0.00 35,707
2024-07-09 Fischetti Gary P Director A-Award A Common Stock 5,771 0.00 27,449
2024-07-09 Capper Joseph H Director A-Award A Common Stock 5,771 0.00 6,239
2024-07-09 CONLEY SHERYL L Director A-Award A Common Stock 5,771 0.00 28,404
2024-06-03 Jellison William R Director A-Award A Common Stock 468 0.00 3,168
2024-06-03 Griffin Stephen D. Officer A-Award A Stock Option (Right to Buy) 96,525 29.35 2.83M 96,525
2024-06-03 Capper Joseph H Director A-Award A Common Stock 468 0.00 468
2024-05-28 Jellison William R Director D Common Stock 0 0.00 2,700
2024-05-28 Capper Joseph H Director D Common Stock 0 0.00 0
2024-03-15 Nunes Anne Officer A-Award A Stock Option (Right to Buy) 26,442 27.98 739.8K 26,442
2024-03-15 Levitz Michael L Officer A-Award A Stock Option (Right to Buy) 51,682 27.98 1.45M 51,682
2024-03-15 Colleran David Officer A-Award A Restricted Stock Unit 19,345 0.00 19,345
2024-03-15 Blanchard Cheryl R Director / Officer A-Award A Stock Option (Right to Buy) 182,699 27.98 5.11M 182,699
2024-03-11 Nunes Anne Officer M-Exempt D Restricted Stock Unit 2,561 0.00 2,561
2024-03-11 Levitz Michael L Officer M-Exempt D Restricted Stock Unit 4,438 0.00 0
2024-03-11 Colleran David Officer M-Exempt D Restricted Stock Unit 3,682 0.00 0
2024-03-11 Blanchard Cheryl R Director / Officer M-Exempt A Common Stock 30,059 0.00 166,228
2023-10-01 Nunes Anne Officer M-Exempt A Common Stock 2,491 0.00 5,784
2023-08-10 Levitz Michael L Officer M-Exempt A Common Stock 3,859 0.00 34,365
2023-06-19 Nunes Anne Officer D Common Stock 0 0.00 4,777
2023-06-14 VOGT SUSAN L N Director A-Award A Common Stock 6,500 0.00 30,278
2023-06-14 Thompson Jeffery S Director A-Award A Common Stock 6,500 0.00 31,575
2023-06-14 Richard Stephen Director A-Award A Common Stock 6,500 0.00 27,936
2023-06-14 Larsen Glenn R. Director A-Award A Common Stock 6,500 0.00 30,323
2023-06-14 HENNEMAN JOHN B III Director A-Award A Common Stock 6,500 0.00 29,936
2023-06-14 Fischetti Gary P Director A-Award A Common Stock 6,500 0.00 21,678
2023-06-14 CONLEY SHERYL L Director A-Award A Common Stock 6,500 0.00 22,633
2023-04-26 Blanchard Cheryl R Director / Officer M-Exempt D Restricted Stock Unit 24,575 0.00 0
2023-04-13 Fischetti Gary P Director A-Award A Common Stock 12,858 0.00 15,178
2023-03-10 Levitz Michael L Officer M-Exempt A Common Stock 8,888 0.00 32,447
2023-03-10 Colleran David Officer M-Exempt A Common Stock 7,663 0.00 22,538
2023-03-10 Blanchard Cheryl R Director / Officer M-Exempt A Common Stock 30,060 0.00 113,791
2023-03-09 Levitz Michael L Officer M-Exempt A Common Stock 4,439 0.00 24,862
2023-03-09 Colleran David Officer M-Exempt D Restricted Stock Unit 3,683 0.00 3,682
2023-03-09 Blanchard Cheryl R Director / Officer M-Exempt A Common Stock 14,419 0.00 87,963
2023-03-04 Colleran David Officer M-Exempt A Common Stock 2,500 0.00 13,007
2022-08-10 Levitz Michael L Officer M-Exempt A Common Stock 3,859 0.00 20,423
2022-06-08 VOGT SUSAN L N Director A-Award A Common Stock 7,954 0.00 23,778
2022-06-08 Thompson Jeffery S Director A-Award A Common Stock 7,954 0.00 25,075
2022-06-08 Richard Stephen Director A-Award A Common Stock 7,954 0.00 21,436
2022-06-08 Larsen Glenn R. Director A-Award A Common Stock 7,954 0.00 23,823
2022-06-08 HENNEMAN JOHN B III Director A-Award A Common Stock 7,954 0.00 23,436
2022-06-08 CONLEY SHERYL L Director A-Award A Common Stock 7,954 0.00 16,133
2022-05-11 Colleran David Officer P-Purchase A Common Stock 1,500 21.37 32.1K 9,867
2022-04-26 Blanchard Cheryl R Director / Officer M-Exempt A Common Stock 24,576 0.00 72,826
2022-03-14 Colleran David Officer P-Purchase A Common Stock 1,500 26.65 40.0K 8,367
2022-03-11 Thompson Jeffery S Director P-Purchase A Common Stock 2,000 24.66 49.3K 17,121
2022-03-11 Levitz Michael L Officer P-Purchase A Common Stock 4,000 24.62 98.5K 15,924
2022-03-11 Colleran David Officer A-Award A Restricted Stock Unit 22,988 0.00 22,988
2022-03-11 Blanchard Cheryl R Director / Officer A-Award A Stock Option (Right to Buy) 208,821 28.14 5.88M 208,821
2022-03-09 Levitz Michael L Officer M-Exempt A Common Stock 4,438 0.00 11,924
2022-03-09 Finnerty Thomas Officer M-Exempt D Restricted Stock Unit 2,548 0.00 5,097
2022-03-09 Colleran David Officer F-InKind D Common Stock 1,081 26.22 28.3K 6,867
2022-03-09 Blanchard Cheryl R Director / Officer M-Exempt D Restricted Stock Unit 14,420 0.00 28,839
2022-03-04 Colleran David Officer F-InKind D Common Stock 734 31.06 22.8K 4,266
2022-02-26 Finnerty Thomas Officer M-Exempt A Common Stock 3,000 0.00 23,679
2022-02-25 Finnerty Thomas Officer M-Exempt A Common Stock 2,834 0.00 21,511
2022-02-09 Finnerty Thomas Officer A-Award A Common Stock 10,125 0.00 21,826
2021-10-28 CONLEY SHERYL L Director A-Award A Common Stock 8,179 0.00 8,179
2021-08-12 Levitz Michael L Officer P-Purchase A Common Stock 777 40.21 31.2K 7,486
2021-08-11 Levitz Michael L Officer P-Purchase A Common Stock 2,850 40.21 114.6K 6,709
2021-08-10 Levitz Michael L Officer M-Exempt D Restricted Stock Unit 3,859 0.00 7,718
2021-07-08 Loerop James Officer M-Exempt A Common Stock 3,000 0.00 6,323
2021-06-16 VOGT SUSAN L N Director A-Award A Common Stock 4,172 0.00 15,824
2021-06-16 Thompson Jeffery S Director A-Award A Common Stock 4,172 0.00 15,121
2021-06-16 Richard Stephen Director A-Award A Common Stock 4,172 0.00 13,482
2021-06-16 Larsen Glenn R. Director A-Award A Common Stock 4,172 0.00 15,869
2021-06-16 LAND RAYMOND J Director A-Award A Common Stock 4,172 0.00 12,125
2021-06-16 HENNEMAN JOHN B III Director A-Award A Common Stock 4,172 0.00 15,482
2021-06-15 Blanchard Cheryl R Director / Officer M-Exempt D Stock Option (Right to Buy) 2,994 33.40 100.0K 101,644
2021-05-18 HENNEMAN JOHN B III Director P-Purchase A Common Stock 2,000 42.86 85.7K 11,310
2021-05-12 LAND RAYMOND J Director S-Sale D Common Stock 2,000 42.60 85.2K 7,953
2021-04-26 Blanchard Cheryl R Director / Officer M-Exempt D Restricted Stock Unit 24,575 0.00 49,151
2021-03-09 Loerop James Officer A-Award A Restricted Stock Unit 6,705 0.00 6,705
2021-03-09 Levitz Michael L Officer A-Award A Restricted Stock Unit 13,315 0.00 13,315
2021-03-09 Finnerty Thomas Officer A-Award A Stock Option (Right to Buy) 19,158 37.40 716.5K 19,158
2021-03-09 Colleran David Officer A-Award A Stock Option (Right to Buy) 27,681 37.40 1.04M 27,681
2021-03-09 Blanchard Cheryl R Director / Officer A-Award A Restricted Stock Unit 43,259 0.00 43,259
2021-03-04 Colleran David Officer M-Exempt D Restricted Stock Unit 2,500 0.00 5,000
2021-02-26 Finnerty Thomas Officer M-Exempt A Common Stock 3,000 0.00 12,582
2021-02-25 Loerop James Officer M-Exempt D Restricted Stock Unit 1,567 0.00 3,133
2021-02-25 Finnerty Thomas Officer F-InKind D Common Stock 832 37.39 31.1K 9,582
2020-11-10 LAND RAYMOND J Director S-Sale D Common Stock 3,446 36.77 126.7K 9,953
2020-10-30 Finnerty Thomas Officer F-InKind D Common Stock 666 32.62 21.7K 7,581
2020-09-03 Richard Stephen Director A-Award A Common Stock 9,310 0.00 9,310
2020-09-03 HENNEMAN JOHN B III Director A-Award A Common Stock 9,310 0.00 9,310
2020-08-10 Levitz Michael L Officer 0 0.00 0
2020-07-09 Loerop James Officer S-Sale D Common Stock 1,244 35.15 43.7K 1,756
2020-07-08 Loerop James Officer A-Award A Common Stock 3,000 0.00 3,000
2020-04-26 Blanchard Cheryl R Director / Officer M-Exempt A Common Stock 4,231 0.00 11,697
2020-03-04 Colleran David Officer A-Award A Stock Option (Right to Buy) 35,000 43.06 1.51M 35,000
2020-02-26 LAND RAYMOND J Director S-Sale D Common Stock 2,700 42.68 115.2K 13,399
2020-02-26 Finnerty Thomas Officer A-Award A Common Stock 3,000 0.00 9,128
2020-02-26 Cheung Sylvia Officer F-InKind D Common Stock 881 42.25 37.2K 49,281
2020-02-25 VOGT SUSAN L N Director A-Award A Common Stock 4,107 0.00 11,652
2020-02-25 Thompson Jeffery S Director A-Award A Common Stock 4,107 0.00 10,949
2020-02-25 Loerop James Officer A-Award A Restricted Stock Unit 4,700 0.00 4,700
2020-02-25 Larsen Glenn R. Director A-Award A Common Stock 4,107 0.00 11,697
2020-02-25 LAND RAYMOND J Director A-Award A Common Stock 4,107 0.00 16,099
2020-02-25 Finnerty Thomas Officer A-Award A Restricted Stock Unit 8,500 0.00 8,500
2020-02-25 Cheung Sylvia Officer A-Award A Restricted Stock Unit 11,700 0.00 11,700
2020-02-25 Bower Joseph L. Director A-Award A Common Stock 4,107 0.00 17,117
2020-02-25 Blanchard Cheryl R Director A-Award A Restricted Stock Unit 4,231 0.00 4,231
2020-02-04 Cheung Sylvia Officer F-InKind D Common Stock 579 40.59 23.5K 47,162
2019-11-27 Bower Joseph L. Director G-Gift D Common Stock 30,000 0.00 13,010
2019-11-08 Cheung Sylvia Officer S-Sale D Common Stock 20,000 59.71 1.19M 47,741
2019-11-06 Cheung Sylvia Officer M-Exempt D Stock Appreciation Rights 35,000 6.36 222.6K 0
2019-10-30 Finnerty Thomas Officer F-InKind D Common Stock 672 69.67 46.8K 6,128
2019-08-28 Larsen Glenn R. Director S-Sale D Common Stock 4,355 57.21 249.1K 7,590
2019-08-20 Bower Joseph L. Director S-Sale D Common Stock 1,994 55.57 110.8K 43,010
2019-08-08 Thompson Jeffery S Director S-Sale D Common Stock 4,843 56.66 274.4K 6,842
2019-07-29 LAND RAYMOND J Director S-Sale D Common Stock 3,000 55.44 166.3K 11,992
2019-07-27 Darling Joseph G Director / Officer F-InKind D Common Stock 2,147 55.85 119.9K 20,289
2019-07-08 Loerop James Officer 0 0.00 0
2019-02-28 Darling Joseph G Director / Officer P-Purchase A Common Stock 1,000 33.20 33.2K 22,436
2019-02-27 Hague Richard Officer A-Award A Stock Option (Right to Buy) 3,777 61.47 232.2K 3,777
2019-02-27 Finnerty Thomas Officer A-Award A Stock Option (Right to Buy) 2,873 61.47 176.6K 2,873
2019-02-27 Darling Joseph G Director / Officer A-Award A Stock Option (Right to Buy) 7,609 61.47 467.7K 7,609
2019-02-27 Cheung Sylvia Officer A-Award A Stock Option (Right to Buy) 7,609 61.47 467.7K 7,609
2019-02-27 Ahn Edward S. Officer A-Award A Stock Option (Right to Buy) 5,625 61.47 345.8K 5,625
2019-02-26 VOGT SUSAN L N Director A-Award A Common Stock 3,842 0.00 7,545
2019-02-26 Thompson Jeffery S Director A-Award A Common Stock 3,842 0.00 11,685
2019-02-26 Larsen Glenn R. Director A-Award A Common Stock 3,842 0.00 11,945
2019-02-26 LAND RAYMOND J Director S-Sale D Common Stock 4,000 33.06 132.2K 14,992
2019-02-26 Hague Richard Officer A-Award A Restricted Stock Unit 9,000 0.00 9,000
2019-02-26 Finnerty Thomas Officer A-Award A Restricted Stock Unit 9,000 0.00 9,000
2019-02-26 Darling Joseph G Director / Officer A-Award A Restricted Stock Unit 63,000 0.00 63,000
2019-02-26 Cheung Sylvia Officer A-Award A Restricted Stock Unit 9,000 0.00 9,000
2019-02-26 Blanchard Cheryl R Director A-Award A Common Stock 3,842 0.00 7,466
2019-02-26 BOWER JOSEPH I Director A-Award A Common Stock 3,842 0.00 45,004
2019-02-26 Ahn Edward S. Officer A-Award A Restricted Stock Unit 4,500 0.00 4,500
2019-02-04 Hague Richard Officer F-InKind D Common Stock 685 38.10 26.1K 21,419
2019-02-04 Cheung Sylvia Officer F-InKind D Common Stock 607 38.10 23.1K 36,422
2019-02-04 Ahn Edward S. Officer F-InKind D Common Stock 685 38.10 26.1K 6,575
2019-02-03 Cheung Sylvia Officer F-InKind D Common Stock 579 37.97 22.0K 37,029
2018-10-26 Hague Richard Officer F-InKind D Common Stock 1,546 35.55 55.0K 22,104
2018-10-23 VOGT SUSAN L N Director A-Award A Common Stock 3,703 0.00 3,703
2018-08-31 Blanchard Cheryl R Director 0 0.00 0
2018-03-09 Darling Joseph G Director / Officer A-Award A Common Stock 7,478 0.00 21,984
2018-03-02 SHERWOOD CHARLES H Director / Officer A-Award A Stock Option (Right to Buy) 27,984 50.13 1.40M 27,984
2018-03-02 Hague Richard Officer A-Award A Stock Option (Right to Buy) 7,788 50.13 390.4K 7,788
2018-03-02 Cheung Sylvia Officer A-Award A Stock Option (Right to Buy) 7,788 50.13 390.4K 7,788
2018-03-02 Ahn Edward S. Officer A-Award A Stock Option (Right to Buy) 7,788 50.13 390.4K 7,788
2018-01-24 WHEELER STEVE E Director A-Award A Common Stock 1,626 0.00 34,594
2018-01-24 Thompson Jeffery S Director A-Award A Common Stock 1,626 0.00 7,843
2018-01-24 SHERWOOD CHARLES H Director / Officer A-Award A Common Stock 57,100 0.00 189,891
2018-01-24 Larsen Glenn R. Director A-Award A Common Stock 1,626 0.00 8,103
2018-01-24 LAND RAYMOND J Director A-Award A Common Stock 1,626 0.00 15,150
2018-01-24 Hague Richard Officer A-Award A Stock Option (Right to Buy) 10,700 61.47 657.7K 10,700
2018-01-24 Finnerty Thomas Officer A-Award A Stock Option (Right to Buy) 6,700 61.47 411.8K 6,700
2018-01-24 Darling Joseph G Officer A-Award A Stock Option (Right to Buy) 21,400 61.47 1.32M 21,400
2018-01-24 Cheung Sylvia Officer A-Award A Stock Option (Right to Buy) 21,400 61.47 1.32M 21,400
2018-01-24 BOWER JOSEPH I Director A-Award A Common Stock 1,626 0.00 41,162
2018-01-24 Ahn Edward S. Officer A-Award A Stock Option (Right to Buy) 13,400 61.47 823.7K 13,400
2017-11-30 Hague Richard Officer S-Sale D Common Stock 5,250 54.48 286.0K 23,650
2017-10-30 Finnerty Thomas Officer A-Award A Stock Option (Right to Buy) 17,000 54.09 919.5K 17,000
2017-10-24 SHERWOOD CHARLES H Director / Officer S-Sale D Common Stock 3,278 60.04 196.8K 132,791
2017-10-23 SHERWOOD CHARLES H Director / Officer S-Sale D Common Stock 22,228 60.06 1.34M 136,069
2017-10-20 SHERWOOD CHARLES H Director / Officer S-Sale D Common Stock 5,991 60.04 359.7K 158,297
2017-10-16 SHERWOOD CHARLES H Director / Officer S-Sale D Common Stock 3,293 60.04 197.7K 0
2017-10-13 SHERWOOD CHARLES H Director / Officer S-Sale D Common Stock 5,216 60.11 313.5K 167,581
2017-10-12 SHERWOOD CHARLES H Director / Officer S-Sale D Common Stock 1,908 60.00 114.5K 172,797

Executive team

Top executives
EBIT / Employee
-38.4K
Shares Outstanding
13.40M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Cheryl R. Blanchard, Ph.D. Executive Chair; Former President and Chief Executive Officer 750.4K 638.0K 3.48M 22.3K 4.89M 71.14%
2 2025 Stephen D. Griffin President and Chief Executive Officer; Former EVP, Chief Financial Officer and Chief Operating Officer 500.0K 300.0K 1.22M 18.1K 2.03M 59.76%
3 2025 David B. Colleran EVP, General Counsel and Secretary 486.4K 219.0K 889.6K 19.2K 1.61M 55.11%
4 2025 Anne M. Nunes Former SVP, Chief Operations Officer 157.6K 505.9K 282.3K 946.6K 53.45%
5 2025 Ian W. McLeod SVP, Chief Accounting Officer and Treasurer 345.4K 122.0K 275.9K 22.3K 765.5K 36.05%
6 2024 Cheryl R. Blanchard, Ph.D. Executive Chair; Former President and Chief Executive Officer 743.9K 497.5K 1.92M 1.92M 28.9K 5.10M 75.11%
7 2024 Cheryl R. Blanchard, Ph.D. President and Chief Executive Officer 743.9K 497.5K 1.92M 1.92M 28.9K 5.10M 75.11%
8 2024 Stephen D. Griffin President and Chief Executive Officer; Former EVP, Chief Financial Officer and Chief Operating Officer 278.8K 300.0K 1.03M 1.03M 12.5K 2.65M 77.65%
9 2024 Stephen D. Griffin EVP, Chief Financial Officer and Treasurer 278.8K 300.0K 1.03M 1.03M 12.5K 2.65M 77.65%
10 2024 Michael L. Levitz Former EVP, Chief Financial Officer and Treasurer 514.6K 100.0K 542.6K 541.7K 75.9K 1.77M 61.09%
11 2024 David B. Colleran EVP, General Counsel and Secretary 482.0K 177.3K 492.1K 491.3K 25.8K 1.67M 58.94%
12 2024 Anne M. Nunes Former SVP, Chief Operations Officer 451.3K 98.4K 277.6K 277.2K 27.2K 1.13M 49.02%
13 2024 Anne M. Nunes SVP, Chief Operations Officer 451.3K 98.4K 277.6K 277.2K 27.2K 1.13M 49.02%
14 2023 Cheryl R. Blanchard, Ph.D. President and Chief Executive Officer 726.0K 583.2K 1.61M 1.51M 26.2K 4.46M 70.06%
15 2023 Cheryl R. Blanchard, Ph.D. Executive Chair; Former President and Chief Executive Officer 726.0K 583.2K 1.61M 1.51M 26.2K 4.46M 70.06%
16 2023 Michael L. Levitz Former EVP, Chief Financial Officer and Treasurer 496.0K 213.4K 474.3K 443.4K 24.8K 1.65M 55.56%
17 2023 Michael L. Levitz EVP, Chief Financial Officer and Treasurer 496.0K 213.4K 474.3K 443.4K 24.8K 1.65M 55.56%
18 2023 David B. Colleran EVP, General Counsel and Secretary 469.9K 202.2K 441.2K 412.5K 24.8K 1.55M 55.06%
19 2023 Anne M. Nunes SVP, Chief Operations Officer 440.0K 158.9K 266.0K 122.5K 26.2K 1.01M 38.33%
20 2023 Anne M. Nunes Former SVP, Chief Operations Officer 440.0K 158.9K 266.0K 122.5K 26.2K 1.01M 38.33%
21 2022 Cheryl R. Blanchard, Ph.D. President and Chief Executive Officer 695.1K 590.8K 2.31M 2.32M 24.4K 5.94M 77.94%
22 2022 Michael L. Levitz Former EVP, Chief Financial Officer and Treasurer 474.6K 213.6K 682.1K 433.7K 22.4K 1.83M 61.09%
23 2022 Michael L. Levitz EVP, Chief Financial Officer and Treasurer 474.6K 213.6K 682.1K 433.7K 22.4K 1.83M 61.09%
24 2022 David B. Colleran EVP, General Counsel and Secretary 449.7K 202.4K 588.0K 399.1K 12.5K 1.65M 59.76%
25 2022 Thomas Finnerty, former EVP, Human Resources 77.4K 21.3K 131.3K 0.00%
26 2022 James Loerop, former EVP, Business Development and Strategic Planning 36.5K 37.2K 73.6K 0.00%
27 2021 Cheryl R. Blanchard, Ph.D. President and Chief Executive Officer 668.4K 568.1K 1.47M 1.47M 23.4K 4.20M 70.02%
28 2021 Michael L. Levitz EVP, Chief Financial Officer and Treasurer 456.4K 205.4K 452.7K 453.0K 21.4K 1.59M 57.00%
29 2021 David B. Colleran EVP, General Counsel and Secretary 432.4K 194.6K 375.6K 375.9K 22.1K 1.40M 53.66%
30 2021 Thomas Finnerty, former EVP, Human Resources 365.9K 164.6K 259.9K 260.1K 53.9K 1.08M 48.35%
31 2021 Thomas Finnerty EVP, Human Resources 365.9K 164.6K 259.9K 260.1K 25.1K 1.08M 48.35%
32 2021 James Loerop, former EVP, Business Development and Strategic Planning 394.9K 228.0K 228.1K 23.4K 874.4K 52.16%
33 2021 James Loerop EVP, Business Development and Strategic Planning 394.9K 228.0K 228.1K 23.4K 874.4K 52.16%
34 2020 Cheryl R. Blanchard, Ph.D. President and Chief Executive Officer 548.1K 458.5K 5.34M 3.66M 28.0K 10.03M 89.68%
35 2020 Michael L. Levitz EVP, Chief Financial Officer and Treasurer 173.1K 73.6K 800.0K 800.0K 11.3K 1.86M 86.11%
36 2020 David Colleran EVP, General Counsel and Secretary 344.1K 143.9K 645.9K 553.4K 18.3K 1.71M 70.32%
37 2020 David B. Colleran EVP, General Counsel and Secretary 344.1K 143.9K 645.9K 553.4K 18.3K 1.71M 70.32%
38 2020 Sylvia Cheung Chief Financial Officer, Treasurer and Assistant Secretary 294.3K 924.6K 89.6K 1.31M 70.66%
39 2020 Thomas Finnerty, former EVP, Human Resources 353.5K 143.2K 626.4K 20.7K 1.14M 54.76%
40 2020 Thomas Finnerty EVP, Human Resources 353.5K 143.2K 626.4K 20.7K 1.14M 54.76%
41 2020 James Loerop, former EVP, Business Development and Strategic Planning 381.6K 171.7K 464.4K 22.2K 1.04M 44.66%
42 2020 James Loerop EVP, Business Development and Strategic Planning 381.6K 171.7K 464.4K 22.2K 1.04M 44.66%
43 2020 Joseph G. Darling President and Chief Executive Officer 80.8K 208.0K 288.8K 0.00%
44 2019 Joseph G. Darling President and Chief Executive Officer 599.5K 764.4K 4.10M 127.5K 5.59M 73.32%
45 2019 James Loerop EVP of Business Development and Strategic Planning 165.9K 202.5K 732.1K 377.8K 1.4K 1.48M 75.01%
46 2019 James Loerop EVP, Business Development and Strategic Planning 165.9K 202.5K 732.1K 377.8K 1.4K 1.48M 75.01%
47 2019 Sylvia Cheung Chief Financial Officer 392.1K 220.6K 585.5K 20.7K 1.22M 48.04%
48 2019 Thomas Finnerty EVP of Human Resources 341.6K 184.4K 585.5K 24.4K 1.14M 51.55%
49 2019 Thomas Finnerty EVP, Human Resources 341.6K 184.4K 585.5K 24.4K 1.14M 51.55%
50 2019 Edward S. Ahn, Ph.D. Chief Technology and Strategy Officer 202.6K 292.8K 184.0K 679.4K 43.09%
51 2018 Charles Sherwood Former Chief Executive Officer 147.9K 3.51M 1.34M 5.00M 70.24%
52 2018 Joseph G. Darling President and Chief Executive Officer 523.5K 412.5K 400.0K 728.3K 105.9K 2.17M 51.99%
53 2018 Joseph Darling Chief Executive Officer and President 523.5K 412.5K 400.0K 728.3K 105.9K 2.17M 51.99%
54 2018 Sylvia Cheung Chief Financial Officer 371.7K 167.2K 728.3K 20.0K 1.29M 56.58%
55 2018 Sylvia Cheung Chief Financial Officer and Treasurer 371.7K 167.2K 728.3K 20.0K 1.29M 56.58%
56 2018 Edward S. Ahn, Ph.D. Chief Technology and Strategy Officer 357.7K 80.5K 455.1K 20.3K 913.6K 49.82%
57 2018 Edward Ahn Chief Technology and Strategy Officer 357.7K 80.5K 455.1K 20.3K 913.6K 49.82%
58 2018 Richard Hague Chief Commercial Officer 335.8K 105.8K 363.3K 22.3K 827.2K 43.92%
59 2018 Thomas Finnerty Chief Human Resources Officer 330.0K 118.8K 285.8K 24.0K 758.6K 37.68%
60 2018 Thomas Finnerty EVP of Human Resources 330.0K 118.8K 285.8K 24.0K 758.6K 37.68%
61 2017 Charles Sherwood Former Chief Executive Officer 622.6K 467.0K 2.96M 187.0K 4.24M 69.87%
62 2017 Charles H. Sherwood, Ph.D. Chief Executive Officer 622.6K 467.0K 2.96M 187.0K 4.24M 69.87%
63 2017 Joseph G. Darling President 182.0K 94.0K 750.0K 750.3K 6.0K 1.78M 84.18%
64 2017 Joseph Darling Chief Executive Officer and President 182.0K 94.0K 750.0K 750.3K 6.0K 1.78M 84.18%
65 2017 Joseph G. Darling President and Chief Executive Officer 182.0K 94.0K 750.0K 750.3K 6.0K 1.78M 84.18%
66 2017 Sylvia Cheung Chief Financial Officer 359.1K 185.8K 709.1K 18.7K 1.27M 55.71%
67 2017 Sylvia Cheung Chief Financial Officer and Treasurer 359.1K 185.8K 709.1K 18.7K 1.27M 55.71%
68 2017 Ed Ahn, Ph.D. Chief Technology and Strategy Officer 347.2K 125.0K 599.3K 19.1K 1.09M 54.95%
69 2017 Edward Ahn Chief Technology and Strategy Officer 347.2K 125.0K 599.3K 19.1K 1.09M 54.95%
70 2017 Edward S. Ahn, Ph.D. Chief Technology and Strategy Officer 347.2K 125.0K 599.3K 19.1K 1.09M 54.95%
71 2017 Richard Hague Chief Commercial Officer 326.0K 102.7K 599.3K 27.1K 1.06M 56.80%
72 2017 Richard Hague Chief Commerical Officer 326.0K 102.7K 599.3K 27.1K 1.06M 56.80%
73 2017 Thomas Finnerty EVP of Human Resources 44.4K 367.8K 301.5K 2.5K 716.2K 93.45%
74 2017 Thomas Finnerty Chief Human Resources Officer 44.4K 367.8K 301.5K 2.5K 716.2K 93.45%
75 2016 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 601.6K 496.3K 861.3K 1.52M 52.1K 3.53M 67.43%
76 2016 Charles Sherwood Former Chief Executive Officer 601.6K 496.3K 861.3K 1.52M 52.1K 3.53M 67.43%
77 2016 Charles H. Sherwood, Ph.D. Chief Executive Officer 601.6K 496.3K 861.3K 1.52M 52.1K 3.53M 67.43%
78 2016 Sylvia Cheung Chief Financial Officer and Treasurer 346.9K 171.7K 301.1K 439.8K 18.7K 1.28M 57.96%
79 2016 Sylvia Cheung Chief Financial Officer 346.9K 171.7K 301.1K 439.8K 18.7K 1.28M 57.96%
80 2016 Richard Hague Chief Commerical Officer 315.0K 127.6K 301.1K 439.8K 84.8K 1.27M 58.42%
81 2016 Richard Hague Chief Commercial Officer 315.0K 127.6K 301.1K 439.8K 84.8K 1.27M 58.42%
82 2016 Ed Ahn, Ph.D. Chief Technology and Strategy Officer 315.7K 156.3K 301.1K 439.8K 18.7K 1.23M 60.16%
83 2016 Edward Ahn Chief Technology and Strategy Officer 315.7K 156.3K 301.1K 439.8K 18.7K 1.23M 60.16%
84 2016 Stephen Mascioli, M.D., MPH Chief Medical Officer 350.0K 759.2K 27.5K 1.14M 66.79%
85 2016 Dana Alexander Chief Operations Officer 285.0K 77.0K 759.2K 13.2K 1.13M 66.93%
86 2015 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 581.2K 508.6K 535.8K 864.0K 52.1K 2.54M 55.07%
87 2015 Charles H. Sherwood, Ph.D. Chief Executive Officer 581.2K 508.6K 535.8K 864.0K 52.1K 2.54M 55.07%
88 2015 Sylvia Cheung Chief Financial Officer 335.2K 188.6K 264.9K 290.0K 18.7K 1.10M 50.57%
89 2015 Richard Hague Chief Commerical Officer 48.5K 727.7K 24.8K 800.9K 90.85%
90 2015 Ed Ahn, Ph.D. Chief Technology and Strategy Officer 305.0K 137.3K 44.0K 18.7K 504.9K 8.70%
91 2015 Frank Luppino Former Chief Operating Officer 135.3K 316.7K 452.0K 29.94%
92 2014 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 564.3K 434.5K 496.3K 694.1K 41.1K 2.23M 53.37%
93 2014 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 564.3K 434.5K 496.3K 694.1K 41.1K 2.23M 53.37%
94 2014 Sylvia Cheung Chief Financial Officer 307.0K 152.0K 195.3K 247.5K 13.7K 915.5K 48.37%
95 2014 Sylvia Cheung Chief Financial Officer 307.0K 152.0K 195.3K 247.5K 13.7K 915.5K 48.37%
96 2014 Ed Ahn, Ph.D. Chief Technology and Strategy Officer 43.4K 733.2K 2.2K 778.7K 94.15%
97 2014 Carol A. Barnett Former Chief Commercial Officer 288.2K 195.3K 247.5K 30.6K 761.7K 58.14%
98 2014 John W. Sheets Jr., Ph.D. Former Chief Scientific Officer 300.8K 61.9K 371.3K 734.0K 8.43%
99 2014 Frank Luppino Former Chief Operating Officer 174.8K 174.8K 0.00%
100 2014 Frank Luppino Chief Operating Officer 174.8K 174.8K 0.00%
101 2013 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 545.2K 572.5K 481.9K 30.0K 1.63M 29.57%
102 2013 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 545.2K 572.5K 481.9K 30.0K 1.63M 29.57%
103 2013 John W. Sheets Jr., Ph.D. 78.5K 38.3K 254.6K 341.4K 51.1K 763.8K 78.03%
104 2013 John W. Sheets Jr., Ph.D. Former Chief Scientific Officer 78.5K 38.3K 254.6K 341.4K 51.1K 763.8K 78.03%
105 2013 Carol A. Barnett Former Chief Commercial Officer 302.9K 149.9K 216.8K 13.8K 683.5K 31.72%
106 2013 Carol A. Barnett Former Chief Commercial Officer 302.9K 149.9K 216.8K 13.8K 683.5K 31.72%
107 2013 Sylvia Cheung Chief Financial Officer 256.6K 144.3K 216.8K 13.4K 631.2K 34.36%
108 2013 Sylvia Cheung Chief Financial Officer 256.6K 144.3K 216.8K 13.4K 631.2K 34.36%
109 2013 Frank Luppino Former Chief Operating Officer 286.8K 289.1K 52.7K 628.6K 45.99%
110 2013 Frank Luppino Former Chief Operating Officer 286.8K 289.1K 52.7K 628.6K 45.99%
111 2013 Frank Luppino Chief Operating Officer 286.8K 289.1K 52.7K 628.6K 45.99%
112 2013 Kevin W. Quinlan Former Chief Financial Officer 77.8K 115.6K 302.8K 496.1K 0.00%
113 2012 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 505.4K 303.4K 32.6K 841.5K 0.00%
114 2012 Frank Luppino Former Chief Operating Officer 326.3K 102.9K 13.2K 442.4K 0.00%
115 2012 Frank Luppino, Chief Operating Officer 326.3K 102.9K 13.2K 442.4K 0.00%
116 2012 Kevin W. Quinlan Former Chief Financial Officer 288.8K 115.6K 17.3K 421.6K 0.00%
117 2011 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 489.3K 404.6K 535.3K 50.8K 1.48M 36.17%
118 2011 Frank Luppino, Chief Operating Officer 315.8K 142.7K 307.1K 13.1K 778.7K 39.44%
119 2011 Kevin W. Quinlan Former Chief Financial Officer 280.2K 120.0K 212.4K 28.8K 641.4K 33.11%
120 2011 Kevin W. Quinlan Chief Financial Officer 280.2K 120.0K 212.4K 28.8K 641.4K 33.11%
121 2010 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 466.0K 214.0K 304.5K 30.8K 1.02M 29.99%
122 2010 Frank Luppino, Chief Operating Officer 285.0K 90.0K 13.0K 555.5K 0.00%
123 2010 Kevin W. Quinlan Former Chief Financial Officer 274.5K 65.0K 76.1K 17.2K 432.9K 17.58%
124 2010 Kevin W. Quinlan Chief Financial Officer 274.5K 65.0K 76.1K 17.2K 432.9K 17.58%
125 2010 William J. Mrachek Vice President of Human Resources 220.6K 49.0K 45.7K 15.7K 331.0K 13.80%
126 2009 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 445.6K 290.5K 116.2K 30.6K 882.9K 13.16%
127 2009 Frank Luppino, Chief Operating Officer 168.8K 68.8K 8.7K 480.5K 0.00%
128 2009 Kevin W. Quinlan Chief Financial Officer 272.4K 71.3K 15.5K 401.6K 0.00%
129 2009 Vice President of Regulatory and Clinical Affairs 239.2K 50.2K 21.2K 15.2K 325.9K 6.52%
130 2009 William J. Mrachek Vice President of Human Resources 219.7K 56.1K 25.5K 17.3K 318.6K 8.00%
131 2008 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 428.5K 192.8K 197.4K 350.8K 24.8K 1.19M 45.90%
132 2008 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 428.5K 192.8K 107.1K 286.0K 24.8K 1.04M 37.83%
133 2008 Kevin W. Quinlan Chief Financial Officer 261.9K 62.6K 38.5K 161.4K 13.6K 537.9K 37.15%
134 2008 Kevin W. Quinlan Chief Financial Officer 261.9K 62.6K 70.9K 125.4K 13.6K 534.4K 36.74%
135 2008 Andrew J. Carter, Ph.D. Chief Technology Officer 240.0K 52.8K 39.0K 52.4K 107.8K 492.0K 18.58%
136 2008 William J. Mrachek Vice President of Human Resources 211.3K 50.7K 44.7K 79.8K 13.5K 399.9K 31.13%
137 2008 William J. Mrachek Vice President of Human Resources 211.3K 50.7K 39.0K 58.6K 13.5K 373.1K 26.17%
138 2008 Irina B. Kulinets Vice President of Regulatory and Clinical Affairs 230.0K 69.0K 20.7K 16.2K 12.2K 348.1K 10.60%
139 2008 Vice President of Regulatory and Clinical Affairs 230.0K 69.0K 38.2K 12.2K 348.1K 10.96%
140 2007 Charles H. Sherwood, Ph.D. President and Chief Executive Officer 412.0K 206.0K 318.7K 24.6K 961.3K 33.16%
141 2007 William J. Mrachek Vice President of Human Resources 197.9K 49.5K 134.2K 12.7K 394.3K 34.04%
142 2006 Charles H. Sherwood President and Chief Executive Officer William J. Knight Chief Financial Officer, Treasurer and Clerk 375.0K 150.0K 316.0K 24.2K 927.7K 34.06%
143 2006 Frank Luppino Vice President—Operations 203.0K 38.2K 147.6K 10.6K 406.7K 36.28%
144 2006 Kevin W. Quinlan Chief Financial Officer 224.0K 42.0K 125.9K 13.1K 390.6K 32.24%
145 2005 Charles H. Sherwood President and Chief Executive Officer 374.4K 187.5K 19.9K 581.8K 0.00%
146 2005 Carol A. Toth Vice President—Research and Development 225.0K 51.8K 11.5K 288.2K 0.00%
147 2005 Frank Luppino Vice President—Operations 195.5K 45.0K 9.9K 250.3K 0.00%
148 2005 Kevin W. Quinlan Chief Financial Officer 97.3K 27.5K 5.1K 130.0K 0.00%
149 2004 Charles H. Sherwood President and Chief Executive Officer 358.3K 230.0K 19.4K 607.6K 0.00%
150 2004 Frank Luppino Vice President—Operations 174.5K 48.8K 8.6K 231.9K 0.00%
151 2004 Carol A. Toth Vice President—Research and Development 21.6K 30.1K 51.7K 0.00%
152 2004 Charles H. Sherwood President and Chief Executive Officer 19.4K 19.4K 0.00%
153 2004 William J. Knight Former Chief Financial Officer 10.5K 10.5K 0.00%
154 2004 Frank Luppino Vice President—Operations 8.6K 8.6K 0.00%
155 2004 James E. O'Neill Chief Accounting Officer and Principal Financial Officer 6.1K 6.1K 0.00%
156 2004 Kevin W. Quinlan Chief Financial Officer
157 2003 Charles H. Sherwood President and Chief Executive Officer 298.7K 150.0K 12.3K 461.0K 0.00%
158 2003 Frank Luppino Vice President—Operations 148.4K 37.5K 7.7K 193.6K 0.00%
159 2003 Roger C. Stikeleather Former Vice President—Sales and Marketing 63.0K 63.0K 0.00%
160 2003 Charles H. Sherwood President and Chief Executive Officer 180.0K 12.3K 12.3K 1,463.18%
161 2003 William J. Knight Former Chief Financial Officer 80.0K 10.3K 10.3K 775.72%
162 2003 Frank Luppino Vice President—Operations 70.0K 7.7K 7.7K 911.22%
163 2003 James E. O'Neill Chief Accounting Officer and Principal Financial Officer 25.0K 5.9K 5.9K 424.95%
164 2003 Carol A. Toth Vice President—Research and Development
165 2003 Kevin W. Quinlan Chief Financial Officer
166 2002 Edward Ross, Jr. Former Vice President—Sales and Marketing Robert E. Tellis Former Senior Vice President—Sales and Marketing 75.0K 102.1K 102.1K 73.47%
167 2002 Charles H. Sherwood President and Chief Executive Officer 100.0K 10.7K 10.7K 932.23%
168 2002 Frank Luppino Vice President—Operations 6.0K 6.5K 6.5K 93.01%
169 2002 Charles H. Sherwood President and Chief Executive Officer William J. Knight Chief Financial Officer, Treasurer and Clerk 75.0K 4.0K 4.0K 1,886.79%
170 2002 William J. Knight Former Chief Financial Officer 75.0K 4.0K 4.0K 1,886.79%
171 2002 James E. O'Neill Chief Accounting Officer and Principal Financial Officer 30.0K 2.8K 2.8K 1,085.38%
172 2001 J. Melville Engle Former President and Chief Executive Officer 317.9K 317.9K 0.00%
173 2001 Michael R. Slater Former Vice President—Operations 123.7K 123.7K 0.00%
174 2001 Charles H. Sherwood President and Chief Operating Officer 150.0K 8.0K 8.0K 1,875.00%
175 2001 Edward Ross, Jr. Former Vice President—Sales and Marketing 8.0K 8.0K 0.00%
176 2000 Edward Ross, Jr. Former Vice President—Sales and Marketing 30.0K 8.0K 8.0K 375.00%
177 2000 Charles H. Sherwood President and Chief Operating Officer 60.0K 8.0K 8.0K 750.00%
178 2000 J. Melville Engle Former President and Chief Executive Officer 60.0K 8.0K 8.0K 750.00%
179 2000 Michael R. Slater Former Vice President—Operations 30.0K 8.0K 8.0K 375.00%
180 1999 Charles H. Sherwood President and Chief Operating Officer 25.0K 8.0K 8.0K 312.50%
181 1999 Michael R. Slater Former Vice President—Operations 55.0K 8.0K 8.0K 687.50%
182 1999 J. Melville Engle Former President and Chief Executive Officer 40.0K 8.0K 8.0K 500.00%
183 1999 Edward Ross, Jr. Former Vice President—Sales and Marketing 25.0K 8.0K 8.0K 312.50%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-28 DEFA14A
2026-04-28 DEF 14A
2025-04-28 DEFA14A
2025-04-28 DEF 14A
2024-06-25 DEFA14A
2024-06-11 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-04 4
2026-04-30 4
2026-04-30 10-Q
2026-04-29 SC 13G
2026-04-29 8-K
2026-04-28 DEFA14A
2026-04-28 DEF 14A
2026-04-28 ARS
2026-03-26 SC 13G/A
2026-03-23 4

Executive team

NameTitleCompensationGender
Cheryl Renee Blanchard Executive Chair 1M
Stephen D. Griffin President, Principal Financial Officer, CEO & Director 795.2K male
David Colleran Executive Vice President, General Counsel & Corporate Secretary 724.6K male
Ben Joseph Vice President of Commercial & Corporate Development male
Mark Namaroff Vice President of Investor Relations, ESG & Corporate Communications male
Matthew Hall Director of Corporate Development & Investor Relations male
Mira Leiwant Senior Vice President of Regulatory, Quality & Clinical Affairs female
Lisa Funiciello VP & Chief Human Resources Officer female
Ian W. McLeod Senior VP, Chief Accounting Officer & Treasurer male
James Chase Senior Vice President of International Sales & Marketing male
ESG Rating
C+
MEDICAL - DEVICES
2007
E (Environmental)
57.9 / 62.5
Company / Sector avg.
S (Social)
59.6 / 68.9
Company / Sector avg.
G (Governance)
69.1 / 64.8
Company / Sector avg.
ESG Total
62.2 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2020-03-02 2021-03-05 Tom Malinowski NJ07 Purchase $1,001 - $15,000
2020-02-28 2021-08-26 Tom Malinowski NJ07 Purchase $1,001 - $15,000
2020-02-27 2021-08-26 Tom Malinowski NJ07 Purchase $1,001 - $15,000
2020-02-26 2021-03-05 Tom Malinowski NJ07 Purchase $15,001 - d
2020-01-28 2021-08-26 Tom Malinowski NJ07 Sale (Partial) $1,001 - $15,000
2019-10-29 2021-08-26 Tom Malinowski NJ07 Sale (Partial) $1,001 - $15,000
2019-08-01 2021-08-26 Tom Malinowski NJ07 Purchase $50,001 - $100,000
2019-07-29 2021-08-26 Tom Malinowski NJ07 Sale (Partial) $1,001 - $15,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits